Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IWWM-11 2022 | Genomic pathways differentiating IgM-MGUS from WM: the microRNA & gene expression landscape

Karan Chohan • 28 Oct 2022
IWWM-11 2022
Lymphoma Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia

Karan Chohan, MD, Mayo Clinic, Rochester, MN, discusses the findings of a study which evaluated the expression of non-coding microRNAs in IgM-MGUS and Waldenström’s macroglobulinemia (WM), and further comments on the role that these microRNAs may play in disease progression. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Karan Chohan

1:20
A real-world study evaluating combined modality therapy for early-stage Hodgkin lymphoma
Karan Chohan • 28 Oct 2022
0:56
Insurance-based disparities in patients with Waldenström’s macroglobulinemia
Karan Chohan • 28 Oct 2022
1:34
WM and the clinical implications of acquired von Willebrand syndrome
Karan Chohan • 28 Oct 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals